Paper11645897
Delaying approval of a critical drug: safety, efficacy, economics, compassion.
Rosenberg LT. J Med Humanit, 1994. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Delaying approval of a critical drug: safety, efficacy, economics, compassion. Papers, record 11645897. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11645897
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Critical Illness | Major topic |
| Drugs, Investigational | Major topic |
| Government Regulation | Major topic |
| Patient Care | Major topic |
| Public Policy | Major topic |
| Social Control, Formal | Major topic |
| United States Food and Drug Administration | Major topic |
| Acquired Immunodeficiency Syndrome | |
| European Union | |
| Federal Government | |
| Government | |
| Human Experimentation | |
| Humans | |
| Infections | |
| Military Personnel | |
| Neoplasms | |
| Patient Advocacy | |
| Politics | |
| United States |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4164249 | Protection against lethality of E. coli endotoxin with "O" antiserum. | Ann N Y Acad Sci | 1966 | https://conductscience.org/library/papers/4164249 | PubMed |
| 2 | 11646205 | A critique of pure reason, a passion to survive: cheating on AIDS trials. | N Y Times Web | 1990 | https://conductscience.org/library/papers/11646205 | PubMed |
| 3 | 3395101 | Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3395101 | PubMed |
| 4 | 2104656 | Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987. | MMWR Morb Mortal Wkly Rep | 1990 | https://conductscience.org/library/papers/2104656 | PubMed |
| 5 | 5038951 | Type-specific and cross-reactive antibodies in gram-negative bacteremia. | N Engl J Med | 1972 | https://conductscience.org/library/papers/5038951 | PubMed |
| 6 | 3306374 | A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3306374 | PubMed |
| 7 | 1865548 | Monoclonal antibodies to endotoxin. New allies against sepsis? | JAMA | 1991 | https://conductscience.org/library/papers/1865548 | PubMed |
| 8 | 2245602 | Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome. | Crit Care Med | 1990 | https://conductscience.org/library/papers/2245602 | PubMed |
| 9 | 2888017 | Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. | N Engl J Med | 1987 | https://conductscience.org/library/papers/2888017 | PubMed |
| 10 | 6752708 | Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. | N Engl J Med | 1982 | https://conductscience.org/library/papers/6752708 | PubMed |
| 11 | 1865542 | A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. | JAMA | 1991 | https://conductscience.org/library/papers/1865542 | PubMed |
| 12 | 1988835 | Monoclonal antibodies and the treatment of gram-negative bacteremia and shock. | N Engl J Med | 1991 | https://conductscience.org/library/papers/1988835 | PubMed |
| 13 | 1988827 | Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. | N Engl J Med | 1991 | https://conductscience.org/library/papers/1988827 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38784667 | Next generation single-domain antibodies against respiratory zoonotic RNA viruses. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/38784667 | PubMed |
| 22531442 | Marketed therapeutic antibodies compendium. | MAbs | 2012 | https://conductscience.org/library/papers/22531442 | PubMed |
| 20711288 | Efficacy and safety of citalopram versus amitriptyline in the treatment of major depression. | Indian J Psychiatry | 2005 | https://conductscience.org/library/papers/20711288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11645897
GET https://conductscience.org/api/papers/v1/11645897/authors